Motoki Fujimaki

Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease

Nobutaka Hattori, Kazuo Yamashiro, N. Hattori, 2017, Scientific Reports.

Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease

Nobutaka Hattori, Takashi Ueno, Naoko Kaga, 2018, Neurology.